re: thoratec tanking & syringe is fair. 1. I can tell you that in my research I have found an expert who thinks the product is OK. I want to be fair and say that. This is the first positive thing I have heard.
2. Thoratec has tanked as indicated by the poster. The reason being that it overestimated the size of the market. Similarly the other standout company Abiomed makes no money. Not a bullish sign.
3. This is not a cut and paste from a competitor. The article is sourced to the University of Columbia and not a doctor working on improving or developing the device and misleadingly called a 'medical investigator'. The doctors are real doctors and not a miserable PhD calling themselves doctor as the CEO of VCR has done.
- Forums
- ASX - By Stock
- VCR
- prop is now the seller.....
VCR
ventracor limited
prop is now the seller....., page-22
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VCR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online